在撒哈拉以南非洲人口中CYP2B6和CYP2A6药物遗传变异的表征
David Twesigomwe1,2, Britt I Drögemöller3, Galen E B Wright4,5
1Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Clinical pharmacology and therapeutics
|December 4, 2023
概括
这项研究描述了撒哈拉以南非洲地区CYP2B6和CYP2A6基因的遗传变异,确定了针对个性化抗逆转录病毒和戒烟疗法至关重要的新星基因.
科学领域:
- 药物基因组学 药物基因组学
- 人类遗传学 人类遗传学
- 人口遗传学 人口遗传学
背景情况:
- 在CYP2B6和CYP2A6的遗传变异影响药物代谢,影响个人对抗逆转录病毒药物和布洛等药物的反应.
- 现有的药物遗传数据对于非洲人口是有限的,这阻碍了非洲大陆的个性化医学方法.
研究的目的:
- 在不同撒哈拉以南非洲人口中描述CYP2B6和CYP2A6明星基因 (哈普型) 的分布.
- 识别和验证这些关键药物代谢基因中的新型药物遗传变异.
主要方法:
- 来自撒哈拉以南非洲的961个人的高深度全基因组测序.
- 使用StellarPGx,Aldy和PyPGx进行生物信息分析来调用恒星等位基因.
- 基因组频率与全球人口的比较,来自1000个基因组项目.
- 使用目标单分子实时 (SMRT) 重序测试验证新型变异的验证.
主要成果:
- 在非洲人群中已知CYP2B6 (例如, *6, *18) 和CYP2A6 (例如, *4, *9, *17) 星基因的详细频率数据.
- 识别了50个潜在的新型非洲祖先恒星等位基因,超过4%的参与者携带预测的新型变异.
- 验证了CYP2A6和CYP2B6的三个新星等位基因,以及几个亚等位基因.
结论:
- 这项研究为非洲人群中代表性不足的CYP2B6和CYP2A6提供了关键的药物遗传频率信息.
- 鉴定新变异突显了在药物基因组学研究中需要采用多样化的人口抽样.
- 这些发现对于开发量身定制的药物遗传学测试和个性化医疗策略至关重要,特别是针对非洲和民中的抗逆转录病毒疗法和戒烟.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
157
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
157
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Nonlinear Pharmacokinetics: Role of Transporters
53
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
53
Factors Affecting Drug Biotransformation: Biological
154
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
154
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K


